Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-glucose Cotransporter-2 Inhibitor”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Testing effectiveness (Phase 2)Study completedNCT06111768
What this trial is testing

Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study

Who this might be right for
Cardiorenal Syndrome
Yale University 30
Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Post-approval studies (Phase 4)Study completedNCT06171802
What this trial is testing

EMPagliflozin After Aortic Valve Replacement

Who this might be right for
Aortic Valve Stenosis
Rigshospitalet, Denmark 206
Post-approval studies (Phase 4)Study completedNCT06825156
What this trial is testing

Metabolic and Renal Outcomes in Cardiac Surgery Patients Receiving SGLT2 Inhibitors

Who this might be right for
Acute Kidney Injury
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 60
Testing effectiveness (Phase 2)Study completedNCT05757791
What this trial is testing

Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
NYU Langone Health 20
Large-scale testing (Phase 3)WithdrawnNCT07057479
What this trial is testing

Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Eurofarma Laboratorios S.A.
Not applicableActive Not RecruitingNCT07198191
What this trial is testing

SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study

Who this might be right for
Acute Myocardial Infarction (AMI)Type 2 Diabetes Mellitus (T2DM)
Yonsei University 200,000
Very early researchLooking for participantsNCT06430684
What this trial is testing

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

Who this might be right for
Chronic Kidney DiseasesPediatric Kidney Disease
Ann & Robert H Lurie Children's Hospital of Chicago 40
Not applicableStudy completedNCT02500186
What this trial is testing

The Clinical Study to Assess the Effect of the Amount of Carbohydrate Intake and Meals Differing in Glycemic Index (GI) in Patients Treated With a Sodium-dependent Glucose Cotransporter 2 (SGLT2) Inhibitor

Who this might be right for
Diabetes Melltius, Type 2
Kansai Electric Power Hospital 24
Testing effectiveness (Phase 2)Looking for participantsNCT06483074
What this trial is testing

Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients

Who this might be right for
End Stage Renal Disease on DialysisPeritoneal Dialysis ComplicationSodium-glucose Cotransporter-2 Inhibitor+1 more
Chinese University of Hong Kong 48
Large-scale testing (Phase 3)WithdrawnNCT06560333
What this trial is testing

ISGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)

Who this might be right for
Diabetes Mellitus, Type 2
Eurofarma Laboratorios S.A.
Large-scale testing (Phase 3)Looking for participantsNCT07653477
What this trial is testing

Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)

Who this might be right for
Type 2 Diabetes
The United Bio-Technology (Hengqin) Co., Ltd. 956
Testing effectiveness (Phase 2)Study completedNCT03316131
What this trial is testing

Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA

Who this might be right for
Asymptomatic Hyperuricemia
AstraZeneca 36
Large-scale testing (Phase 3)Enrolling By InvitationNCT07065357
What this trial is testing

Treating the Metabolic Syndrome With a Sodium-glucose Cotransporter-2 Inhibitor

Who this might be right for
Metabolic Syndrome
The University of Hong Kong 160
Testing effectiveness (Phase 2)Looking for participantsNCT06528405
What this trial is testing

The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease

Who this might be right for
Acute Kidney Injury
National Taiwan University Hospital 264
Post-approval studies (Phase 4)Looking for participantsNCT06668389
What this trial is testing

Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial

Who this might be right for
Congenital Heart DiseaseRepaired Tetralogy of Fallot (rTOF)Pulmonary Regurgitation+2 more
The University of Hong Kong 106
Large-scale testing (Phase 3)Study completedNCT04350593
What this trial is testing

Dapagliflozin in Respiratory Failure in Patients With COVID-19

Who this might be right for
COVID-19
Saint Luke's Health System 1,250
Not applicableStudy completedNCT05764811
What this trial is testing

SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity

Who this might be right for
Fatty Liver Disease
National Cheng-Kung University Hospital 40
Post-approval studies (Phase 4)Ended earlyNCT05139914
What this trial is testing

Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Endothelial Dysfunction
Boston University 4
Post-approval studies (Phase 4)Looking for participantsNCT07240844
What this trial is testing

Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy

Who this might be right for
Amyloid Cardiomyopathy
Seoul St. Mary's Hospital 68
Next Page